Clinical Trials Directory

Trials / Terminated

TerminatedNCT01475929

Effect of Probiotic Supplement on Bowel Function

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
149 (actual)
Sponsor
Danisco · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to analyse the effect of probiotic supplement on symptoms of irritable bowel syndrome.

Detailed description

The aim of the intervention is to analyse the effect of a probiotic supplement in a dose-responsive set up on symptoms of irritable bowel syndrome (IBS). Fulfillment of Rome III criteria will be used as inclusion criterion. Subjective assessment of bowel symptoms, IBS-related quality of life and adequate relief will be assessed as outcome measures.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic supplementA single strain probiotic supplement given at two doses

Timeline

Start date
2011-06-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2011-11-22
Last updated
2015-08-13

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01475929. Inclusion in this directory is not an endorsement.

Effect of Probiotic Supplement on Bowel Function (NCT01475929) · Clinical Trials Directory